AD has approximately equal amounts of 3R- and 4R-tau contained within pathological structures whereas other tauopathies, such as corticobasal degeneration (CBD) or Pick’s disease exhibit, respectively, predominantly 4R- or 3R-tau pathology (for review, see [18]). The gene discussed is MAPT; the disease is Alzheimer disease.